Archer Daniels enters technology licensing agreement with Solarea Bio » 10:1810/1910/19/21
Solarea Bio announced it…
Story temporarily locked.
Archer Daniels and enzymes, probiotics maker Vland to launch JV for China » 08:1410/1810/18/21
ADM and Qingdao Vland…
ADM and Qingdao Vland Biotech Group announced that they have agreed to form a joint venture to serve growing Chinese demand for human probiotics. "This exciting new joint venture represents the latest expansion in our full-scale global health & wellness business, which is helping propel growth across our entire human and animal nutrition portfolio, and creating value for ADM and customers alike," said Vince Macciocchi, president of ADM's Nutrition business. "We're excited to partner with Vland to help meet the needs of consumers who are becoming increasingly aware of the strong linkage between health of the gut microbiome and their overall health. Retail demand for probiotics in China is estimated to be $1 billion in 2022, with annual growth of more than 9 percent, and we believe this new venture - powered by the expertise and experience of both ADM and Vland - is perfectly positioned to play a leading role in meeting that demand." The 50-50 joint venture will manufacture and sell human probiotics, bringing together expertise and experience from both ADM and Vland to encompass a full range of technology, production and commercial capabilities, from pre-clinical trial design to manufacturing to go-to-market strategy and execution. The joint venture, which is subject to regulatory approval, is expected to launch in the first half of 2022.
Applied Materials unveils eBeam metrology system » 07:3810/1810/18/21
Applied Materials unveiled a unique eBeam metrology system that enables a new playbook for patterning control based on massive on-device, across-wafer and through-layer measurements. The company said, "Advanced chips are built one layer at a time, and each of billions of individual features must be perfectly patterned and aligned to create working transistors and interconnects with optimal electrical characteristics. As the industry increasingly moves from simple 2D designs to more aggressive multipatterning and 3D designs, a commensurate breakthrough in metrology is needed to perfect each critical layer and enable the best performance, power, area-cost and time to market...With the arrival of new eBeam system technology that can directly measure semiconductor device structures across the wafer and through layers at high speed, customers are moving to a new patterning control playbook based on big data. Applied's latest eBeam metrology innovation - the PROVision 3E system - is especially designed for this new playbook."
Piper Sandler starts Applied Materials at Neutral with $130 price target » 16:1710/1410/14/21
Piper Sandler analyst…
Piper Sandler analyst Weston Twigg initiated coverage of Applied Materials with a Neutral rating and $130 price target. While Twigg believes the company should benefit from a multi-year expansion of compute and semiconductor demand, a likely 2023 "digestion period" could limit share upside over the next 12 months, the analyst stated. However, he adds that shareholder returns "should remain high" and that he believes the company's 2024 target model "appears achievable."
Applied Materials initiated with a Neutral at Piper Sandler » 16:1110/1410/14/21
Piper Sandler analyst…
Piper Sandler analyst Weston Twigg initiated coverage of Applied Materials with a Neutral rating and $130 price target.
Steris, Sotera sites on EPA list for required TRI reporting, says Baird » 14:0110/1410/14/21
Baird analyst Mike Polark…
Baird analyst Mike Polark noted that the Environmental Protection Agency has announced a decision to exercise its authority under the Emergency Planning and Community Right-to-Know Act to make Toxic Release Inventory, or TRI, reporting at 31 ethylene oxide sterilization facilities in the U.S., which has previously been voluntary, a mandatory requirement. The 31 facilities selected by the EPA include eight sites owned by Sterigenics, a Sotera Health (SHC) company, and eight sites owned by Steris (STE), noted Polark. He adds that while "none of this is actionable per se" he is watching this "developing, sensitive industry topic." Polark has Outperform ratings on both Sotera Health and Steris.
|Over a week ago|
Fly Intel: Top five analyst downgrades » 09:5410/1210/12/21
LITE, CTXS, TREX, ADM, FBNC
Catch up on today's…
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lumentum (LITE) downgraded to Outperform from Strong Buy at Raymond James with analyst Simon Leopold saying Lumentum remains his favorite play on optical components but that its December quarter outlook carries risk. 2. Citrix (CTXS) downgraded to Market Perform from Outperform at William Blair with analyst Jason Ader saying recent discussions with the company's key technology partners "speak to a dire and deteriorating situation at Citrix." 3. Trex Company (TREX) downgraded to Neutral from Outperform at Baird with analyst Timothy Wojs saying decking channel checks suggest sell-through demand will be slower in Q3 and Q4, driven by a combination of material and labor constraints, tougher compares, inflation and seasonality. 4. Archer Daniels (ADM) downgraded to Equal Weight from Overweight at Stephens with analyst Ben Bienvenu saying while he thinks fundamentals remain strong for Archer Daniels, he views the current risk/reward as "more subdued than we've seen" and believes that for the stock to move materially higher, fundamentals will "need to inflect significantly given the stock's current valuation." 5. First Bancorp (FBNC) downgraded to Neutral from Overweight at Piper Sandler with analyst Stephen Scouten saying the shares appear near full value following the recent outperformance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
Archer Daniels downgraded to Equal Weight from Overweight at Stephens » 07:5110/1210/12/21
Stephens analyst Ben…
Stephens analyst Ben Bienvenu downgraded Archer Daniels to Equal Weight from Overweight with a price target of $67, up from $65. While he thinks fundamentals remain strong for Archer Daniels, he views the current risk/reward as "more subdued than we've seen" and believes that for the stock to move materially higher, fundamentals will "need to inflect significantly given the stock's current valuation," Bienvenu tells investors. He is lowering his Q3 earnings estimate primarily on lower-than-previously-expected results in the Ag Services and Vantage operating segments given how disruptions from Hurricane Ida likely pushed volumes that would have flowed through Q3 into late Q4 and the first quarter of 2022, Bienvenu added.
AIG price target raised to $59 from $53 at Barclays » 05:3710/1210/12/21
AIG, PLMR, ACGL
Barclays analyst Tracy…
Barclays analyst Tracy Benguigui raised the firm's price target on AIG to $59 from $53 and keeps an Equal Weight rating on the shares ahead of the Q3 reporting season. The analyst likes insurers "who truly embrace the cycle by growing through risk optimization." Benguigui anticipates Palomar (PLMR), AIG (AIG) and Arch Capital (ACGL) to show the strongest growth prospects in Q3.
Fly Intel: After-Hours Movers » 18:4710/1110/11/21
WWR, QTRX, GERN, ACGL, VCYT, RLAY
Check out this evening's…